Peptide Thymosin Alpha 1
Thymosin alpha 1 (T α 1) is a peptide, produced naturally by the thymus gland. The thymus is where immune cells known as T cells mature and are released when prompted to do so by the Thymosin Aplaha 1. T cell production and action within the body is vital to adaptive immunity. This is the mechanism by which immune cells are able to recognize and kill foreign invaders. Specifically, Thymosin alpha 1 has been shown to enhance the function of the immune system’s cells called T and dendritic cells. These white blood cells play pivotal roles in the body’s defense process and this versatile peptide can be given to anyone with a depressed immune system or suffering from an infection.
Benefits of Thymosin-alpha 1:
- Exhibits antibacterial and antifungal properties
- Suppresses tumor growth
- Help eradicate the unhealthy cells and stop the infection or cancer growth
- Protects against oxidative damage
- Enhances vaccine effectiveness
IMMUNE SYSTEM EFFECTS
T cells, for example, come in two forms: killer and helper T cells. Killer T cells are responsible for hunting down and destroying our body’s own cells that are cancerous or infected with bacteria or viruses. Helper cells work with the other cells of the immune system to orchestrate and carry out appropriate immune responses.
APPROVED AS A MEDICATION OUTSIDE THE US
Thymosin Alpha 1 is approved for use as a medication in over 35 countries around the world for the treatment of hepatitis B, hepatitis C, other infections, and also as an adjunct to other cancer treatments in order to boost the patient’s immune capabilities.. Here in the US Thymosin Alpha 1 is the active ingredient in the immune modulating drug, Zadaxin®. used to treat hepatitis B and C and also used to support the depressed immune systems of cancer patients who have previously, or are undergoing chemotherapy. It has also been studied and /or used to treat malignant melanoma, hepatocellular carcinoma, drug-resistant tuberculosis, chronic fatigue as well as a variety of other cancers and chronic viral disease and Lyme disease.
MECHANISM OF ACTION
Persons fighting infection have a lowered number off circulating T α 1 and suppressed helper T cell numbers compared to healthy individuals. This is problematic, as the optimal immune function is vital to recovery from infection. Supplementation with T α 1 has the potential for great therapeutic benefit for patients suffering from an infection or autoimmune disease.
T α 1 assists the immune system in the location and eradication of the Lyme bacteria and infected cells, while helping to prevent oxidative damage, thereby decreasing inflammation and enabling a better quality of life throughout treatment.